Michel Fontes

Université de Provence. Section sciences 
"Michel Fontes"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Rahman F, Bordignon B, Culerrier R, et al. (2016) Ascorbic acid drives the differentiation of mesoderm-derived embryonic stem cells. Involvement of p38 MAPK/CREB and SVCT2 transporter. Molecular Nutrition & Food Research
Mones S, Gess B, Bordignon B, et al. (2016) Erratum to: CMTX1 patients' cells present genomic instability corrected by CamKII inhibitors. Orphanet Journal of Rare Diseases. 11: 6
Rahman F, Al Frouh F, Bordignon B, et al. (2014) Ascorbic acid is a dose-dependent inhibitor of adipocyte differentiation, probably by reducing cAMP pool. Frontiers in Cell and Developmental Biology. 2: 29
Mones S, Bordignon B, Peiretti F, et al. (2014) CamKII inhibitors reduce mitotic instability, connexon anomalies and progression of the in vivo behavioral phenotype in transgenic animals expressing a mutated Gjb1 gene. Frontiers in Neuroscience. 8: 151
Sallée M, Fontès M, Louis L, et al. (2013) Alternative splicing events is not a key event for gene expression regulation in uremia. Plos One. 8: e82702
Bordignon B, Chiron J, Fontés M. (2013) Ascorbic acid derivatives as a new class of antiproliferative molecules. Cancer Letters. 338: 317-27
Rahman F, Fontes M. (2013) Ascorbic acid, myelination and associated disorders Pharmanutrition. 1: 98-100
Mones S, Bordignon B, Fontes M. (2012) Connexin 32 is involved in mitosis. Glia. 60: 457-64
Bataille S, Berland Y, Fontes M, et al. (2011) High Resolution Melt analysis for mutation screening in PKD1 and PKD2. Bmc Nephrology. 12: 57
Bataille S, Demoulin N, Devuyst O, et al. (2011) Association of PKD2 (polycystin 2) mutations with left-right laterality defects. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 58: 456-60
See more...